RE:RE:Base is reachedYou would think now that SBM is down to 2.5 months to achieve very significant milestones including a Phase I clinical trial, Animal use contract and further TFC1067 contracts and partners that there would be volume and share price increase in anticipation. Instead the stock is drifting down on both those metrics. Guess the market doesn't believe Howard the CEO that cried Wolf so many times we've lost track. Time to either finalize something.....anything or get the hell out of the way and hire a professional to shepherd this company to some kind of success cause years of stumbles, fumbles and complete screw ups are enough!